Physiological Pacing Clinical Trial
— LEVEL-ATOfficial title:
LEft VEntricuLar Activation Time Shortening With Physiological Pacing vs Biventricular Resynchronization Therapy: a Randomized Study (LEVEL-AT)
Verified date | August 2022 |
Source | Hospital Clinic of Barcelona |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The LEVEL-AT Trial (LEft VEntricuLar Activation Time Shortening with Physiological Pacing vs Biventricular Resynchronization therapy: a randomized study) is a non-inferiority study that aims to determine if physiological pacing could decrease the left ventricular activation time compared with biventricular therapy.
Status | Completed |
Enrollment | 70 |
Est. completion date | June 30, 2022 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - The patient must indicate their acceptance to participate in the study by signing an informed consent document. - The patient must be = 18 years of age. - Left bundle branch block, QRS =130 and FEVI <=35% (Indication of cardiac resynchronization IA or IB ESC Guidelines). No indication of stimulation for AV block. - Patients with indication of resynchronization therapy for ventricular dysfunction and indication of cardiac stimulation for AV block according to ESC Guidelines (IA ESC Guidelines). - Non-left bundle branch block, QRS =150 and FEVI <=35% (Indication of cardiac resynchronization IIaB ESC Guidelines). Exclusion Criteria: - Myocardial infarction, unstable angina or cardiac revascularization during the previous 3 months. - Pregnancy. - Participating currently in a clinical investigation that includes an active treatment. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Clinic de Barcelona | Barcelona | Select |
Lead Sponsor | Collaborator |
---|---|
Josep Lluis Mont Girbau | Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Left ventricular activation time. | Left ventricular activation time measured by eletrocardiographic imaging. | 45 days | |
Secondary | QRS duration. | QRS duration (milliseconds) measured with a 12-lead ECG. | Implant, 6 months and 12 months. | |
Secondary | Left ventricular activation time. | Left ventricular activation time measured by eletrocardiographic imaging | 6 months and 12 months. | |
Secondary | Change in left ventricular function. | Left ventricular ejection fraction measured with Simpson method with echocardiography. | 6 months and 12 months. | |
Secondary | Change in end-systolic volume. | End-systolic volume measured with echocardiography. | 6 months and 12 months. | |
Secondary | Change in NYHA functional class. | NYHA functional class I, II, III, IV. | 6 months and 12 months. | |
Secondary | Hospitalization due to heart failure or mortality (combined endpoint). | Hospitalization: patient hospitalization (yes/no) Mortality: mortality (yes/no) | 1 year. | |
Secondary | Correction of septal flash | Correction of septal flash determined with echocardiography (M mode) | 15 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01996397 -
Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy
|
N/A | |
Active, not recruiting |
NCT05187611 -
Conduction System Pacing vs Biventricular Resynchronization Therapy in Systolic Dysfunction and Wide QRS: CONSYST-CRT.
|
N/A | |
Active, not recruiting |
NCT05155865 -
Conduction System Pacing Versus Biventricular Pacing for Cardiac resYNChronization
|
N/A |